190 related articles for article (PubMed ID: 37530158)
1. Celecoxib and bevacizumab synergistically inhibit non-small cell lung cancer by inducing apoptosis and modulating VEGF and MMP-9 expression.
Qadir A; Khalid Z; Kashan Theba F; Mujtaba Ali M; Asif M; Rizvi F
Pak J Pharm Sci; 2023 Mar; 36(2):501-506. PubMed ID: 37530158
[TBL] [Abstract][Full Text] [Related]
2. Relationship between epidermal growth factor receptor (EGFR) mutation and serum cyclooxygenase-2 Level, and the synergistic effect of celecoxib and gefitinib on EGFR expression in non-small cell lung cancer cells.
Li N; Li H; Su F; Li J; Ma X; Gong P
Int J Clin Exp Pathol; 2015; 8(8):9010-20. PubMed ID: 26464643
[TBL] [Abstract][Full Text] [Related]
3. Parthenolide inhibits tumor-promoting effects of nicotine in lung cancer by inducing P53 - dependent apoptosis and inhibiting VEGF expression.
Talib WH; Al Kury LT
Biomed Pharmacother; 2018 Nov; 107():1488-1495. PubMed ID: 30257366
[TBL] [Abstract][Full Text] [Related]
4. Celecoxib inhibits cell growth and modulates the expression of matrix metalloproteinases in human osteosarcoma MG-63 cell line.
Zhou X; Shi X; Ren K; Fan GT; Wu SJ; Zhao JN
Eur Rev Med Pharmacol Sci; 2015 Nov; 19(21):4087-97. PubMed ID: 26592832
[TBL] [Abstract][Full Text] [Related]
5. Expression of HAb18G in non-small lung cancer and characterization of activation, migration, proliferation, and apoptosis in A549 cells following siRNA-induced downregulation of HAb18G.
Xu X; Liu S; Lei B; Li W; Lin N; Sheng W; Huang A; Shen H
Mol Cell Biochem; 2013 Nov; 383(1-2):1-11. PubMed ID: 24013786
[TBL] [Abstract][Full Text] [Related]
6. Tanshinone IIA combined with adriamycin inhibited malignant biological behaviors of NSCLC A549 cell line in a synergistic way.
Xie J; Liu JH; Liu H; Liao XZ; Chen Y; Lin MG; Gu YY; Liu TL; Wang DM; Ge H; Mo SL
BMC Cancer; 2016 Nov; 16(1):899. PubMed ID: 27863471
[TBL] [Abstract][Full Text] [Related]
7. Cytochrome P450 ω-hydroxylase promotes angiogenesis and metastasis by upregulation of VEGF and MMP-9 in non-small cell lung cancer.
Yu W; Chen L; Yang YQ; Falck JR; Guo AM; Li Y; Yang J
Cancer Chemother Pharmacol; 2011 Sep; 68(3):619-29. PubMed ID: 21120482
[TBL] [Abstract][Full Text] [Related]
8. Curcumin sensitizes human lung cancer cells to apoptosis and metastasis synergistically combined with carboplatin.
Kang JH; Kang HS; Kim IK; Lee HY; Ha JH; Yeo CD; Kang HH; Moon HS; Lee SH
Exp Biol Med (Maywood); 2015 Nov; 240(11):1416-25. PubMed ID: 25716014
[TBL] [Abstract][Full Text] [Related]
9. Death receptor regulation and celecoxib-induced apoptosis in human lung cancer cells.
Liu X; Yue P; Zhou Z; Khuri FR; Sun SY
J Natl Cancer Inst; 2004 Dec; 96(23):1769-80. PubMed ID: 15572759
[TBL] [Abstract][Full Text] [Related]
10. Synergistic effect of bevacizumab and celecoxib on angiogenesis in vitro using human umbilical vein endothelial cells.
Qadir A; Wahid M; Asif M; Roome T
Int J Clin Pharmacol Ther; 2020 Dec; 58(12):696-702. PubMed ID: 32909536
[TBL] [Abstract][Full Text] [Related]
11. Platycodon D-induced A549 Cell Apoptosis through RRM1-Regulated p53/VEGF/ MMP2 Pathway.
Li J; Ma A; Lan W; Liu Q
Anticancer Agents Med Chem; 2022; 22(13):2458-2467. PubMed ID: 35088678
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA SNHG15 indicates poor prognosis of non-small cell lung cancer and promotes cell proliferation and invasion.
Dong YZ; Meng XM; Li GS
Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2671-2679. PubMed ID: 29771418
[TBL] [Abstract][Full Text] [Related]
13. [Effect of bevacizumab on proliferation and invasion of human lung cancer A549 cells].
Wang D; Han Y; Zhu L; Deng L; Qu D; Cui F; Xu Y
Zhonghua Zhong Liu Za Zhi; 2015 Aug; 37(8):573-7. PubMed ID: 26714596
[TBL] [Abstract][Full Text] [Related]
14. Effects of autocrine vascular endothelial growth factor (VEGF) in non-small cell lung cancer cell line A549.
Wang Y; Huang L; Yang Y; Xu L; Yang J; Wu Y
Mol Biol Rep; 2013 Apr; 40(4):3093-9. PubMed ID: 23459872
[TBL] [Abstract][Full Text] [Related]
15. TNF-related apoptosis-inducing ligand enhances vinorelbine-induced apoptosis and antitumor activity in a preclinical model of non-small cell lung cancer.
Zhu K; Fang W; Chen Y; Lin S; Chen X
Oncol Rep; 2014 Sep; 32(3):1234-42. PubMed ID: 25017445
[TBL] [Abstract][Full Text] [Related]
16. [Effects of cetuximab combined with celecoxib on apoptosis and KDR and AQP1 expression in lung cancer].
Xia H; Ye J; Bai H; Wang C
Zhongguo Fei Ai Za Zhi; 2013 Dec; 16(12):625-31. PubMed ID: 24345486
[TBL] [Abstract][Full Text] [Related]
17. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
Zhou Y; Li S; Li J; Wang D; Li Q
Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of riccardin D on growth of human non-small cell lung cancer: in vitro and in vivo studies.
Xue X; Sun DF; Sun CC; Liu HP; Yue B; Zhao CR; Lou HX; Qu XJ
Lung Cancer; 2012 Jun; 76(3):300-8. PubMed ID: 22261315
[TBL] [Abstract][Full Text] [Related]
19. Enhanced growth inhibition and apoptosis induction in NSCLC cell lines by combination of celecoxib and 4HPR at clinically relevant concentrations.
Sun SY; Schroeder CP; Yue P; Lotan D; Hong WK; Lotan R
Cancer Biol Ther; 2005 Apr; 4(4):407-13. PubMed ID: 15846100
[TBL] [Abstract][Full Text] [Related]
20. Suppression of growth, migration and invasion of highly-metastatic human breast cancer cells by berbamine and its molecular mechanisms of action.
Wang S; Liu Q; Zhang Y; Liu K; Yu P; Liu K; Luan J; Duan H; Lu Z; Wang F; Wu E; Yagasaki K; Zhang G
Mol Cancer; 2009 Oct; 8():81. PubMed ID: 19796390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
